iSpecimen (ISPC)
NASDAQ:ISPC
Want to see ISPC full AI Analyst Report?
ISPC Stock Chart & Stats
$0.31
-$0.03(-1.03%)
At close: 4:00 PM EST
$0.31
-$0.03(-1.03%)
Day’s Range― - ―
52-Week Range$4.00 - $127.20
Previous CloseN/A
Volume25.67K
Average Volume (3M)8.88M
Market Cap
$7.11M
Enterprise Value-$5.79M
Total Cash (Recent Filing)$6.88M
Total Debt (Recent Filing)$268.80K
Price to Earnings (P/E)―
Beta1.40
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,316,032
10 Day Avg. Volume698,577
30 Day Avg. Volume8,882,166
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.39
Price to Sales (P/S)0.62
P/FCF Ratio-0.28
Enterprise Value/Market Cap-0.81
Enterprise Value/Revenue-3.00
Enterprise Value/Gross Profit-240.09
Enterprise Value/Ebitda0.66
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Marketplace Platform & NetworkA technology-enabled marketplace that facilitates biospecimen transactions creates durable network effects: more suppliers attract more buyers and vice versa. As a service-fee model, scale and deeper supplier coverage (including rare specimens) can sustain recurring revenues and raise switching costs for customers over months.
SalesStack Digital IntegrationFull platform integration and AI-assisted matching are structural operational upgrades that reduce manual work, speed onboarding, and lower infrastructure costs. These capabilities improve scalability and order throughput, supporting more efficient growth and healthier long-term unit economics if volume recovers.
Streamlined Global ShippingDirect supplier-to-customer shipping materially reduces transit times and handling costs and expands access to international and rare specimens. Improved logistics raise service reliability and customer satisfaction, strengthening competitive differentiation and making the marketplace more attractive to repeat research clients.
Bears Say
Revenue & Margin CollapseA sharp drop in revenue and a collapse in gross margin signal a severe deterioration of core transaction economics. For a commission-based marketplace, such moves erode pricing power and the ability to cover fixed costs, undermining sustainable profitability and limiting capacity to reinvest in growth over the coming months.
Persistent Cash BurnConsistent negative operating and free cash flow depletes runway and forces reliance on external financing. With limited internal cash generation, the company faces pressure to raise capital or cut investment, which can dilute shareholders or constrain product, supplier, and customer investments needed to restore volume and margins.
Governance & Market-compliance StrainA reverse split to meet listing rules and repeated quorum failures indicate weak shareholder engagement and market distress. These governance and compliance headwinds can deter institutional investors, complicate capital raises, and delay approval-dependent strategic actions, limiting execution flexibility over months.
iSpecimen News
ISPC FAQ
What was iSpecimen’s price range in the past 12 months?
iSpecimen lowest stock price was $4.00 and its highest was $127.20 in the past 12 months.
What is iSpecimen’s market cap?
iSpecimen’s market cap is $7.11M.
When is iSpecimen’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were iSpecimen’s earnings last quarter?
Currently, no data Available
Is iSpecimen overvalued?
According to Wall Street analysts iSpecimen’s price is currently Overvalued.
Does iSpecimen pay dividends?
iSpecimen does not currently pay dividends.
What is iSpecimen’s EPS estimate?
iSpecimen’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does iSpecimen have?
iSpecimen has 1,316,032 shares outstanding.
What happened to iSpecimen’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of iSpecimen?
Currently, no hedge funds are holding shares in ISPC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
iSpecimen
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.
Technical Analysis
―
Intelligent Bio Solutions
―
BioNexus Gene Lab Corp
―
―
bioAffinity Technologies, Inc.
―
Ownership Overview
―
Insiders
4.92% Mutual Funds
― Other Institutional Investors
94.98% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---